Pure Global AI
NCT04160078Completed

Mindfulness IN-home for Diabetes and Sleep Health

Adapting a Mindfulness Intervention to Improve Sleep and Reduce Diabetes Risk Among a Diverse Sample in Atlanta
Emory UniversityClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Diabetes,Diabetes Mellitus, Type 2
Drug/Device/Intervention
Mindfulness-based stress reduction (MBSR) Intervention
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Emory University
Location
Atlanta, United States of America
Timeline & enrollment
Phase
N/A
Start date
Dec 18, 2019
End date
Aug 29, 2021
Enrollment
18 participants
Primary outcome

Change in average nightly sleep duration from baseline,Change in sleep timing from baseline,Change in sleep quality from baseline

Summary

The study investigates the effects of a mindfulness intervention on sleep and subsequent
 cardio-metabolic risk in an adult Atlanta population aged 18 and older.

ICD-10 classifications
Type 2 diabetes mellitusType 2 diabetes mellitus with other specified complicationsType 2 diabetes mellitus with unspecified complicationsType 2 diabetes mellitus without complicationsType 2 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04160078
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04160078 through Pure Global AI's free database. This phase not specified trial is sponsored by Emory University and is currently Completed. The study focuses on Diabetes,Diabetes Mellitus, Type 2. Target enrollment is 18 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.